eNOS Pharmaceuticals, Inc.

eNOS Pharmaceuticals, Inc. develops therapies used to treat various cardiovascular, Alzheimer's diseases, and the ischemic stroke. It offers prophylactic treatment regime that enhances blood vessel capacity to vasodilate. The company also develops products that improve and restore blood flow through the up-regulation of endothelial nitric oxide synthase. eNOS Pharmaceuticals, Inc. is based in Lexington, Massachusetts.